Fidelity Investments
HOWL icon

Fidelity Investments’s Werewolf Therapeutics HOWL Stock Holding History

Fidelity Investments’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32 Sell
39
-3,592
-99% -$2.46K ﹤0.01% 5323
2025
Q4 		$2.3K Sell
3,631
-7,653
-68% -$9.3K ﹤0.01% 5000
2025
Q3 		$22.2K Hold
11,284
– – ﹤0.01% 4312
2025
Q2 		$12.3K Buy
11,284
+6,823
+153% +$7.02K ﹤0.01% 4462
2025
Q1 		$4.34K Buy
4,461
+2,630
+144% +$3.44K ﹤0.01% 4743
2024
Q4 		$2.71K Buy
1,831
+317
+21% +$646 ﹤0.01% 4759
2024
Q3 		$3.21K Buy
1,514
+1,511
+50,367% +$3.44K ﹤0.01% 4713
2024
Q2 		$7 Buy
+3
New +$14 ﹤0.01% 5305
2023
Q3 		– Sell
-2,100
Closed -$6.41K – 5405
2023
Q2 		$6.41K Hold
2,100
– – ﹤0.01% 4285
2023
Q1 		$5.46K Buy
+2,100
New +$6.26K ﹤0.01% 4364
2022
Q4 		– Sell
-337,073
Closed -$1.52M – 5461
2022
Q3 		$1.52M Sell
337,073
-181,699
-35% -$987K ﹤0.01% 2507
2022
Q2 		$2.12M Buy
518,772
+137
+0% +$625 ﹤0.01% 2482
2022
Q1 		$2.28M Buy
518,635
+147,901
+40% +$1.04M ﹤0.01% 2566
2021
Q4 		$4.42M Buy
370,734
+132,234
+55% +$2M ﹤0.01% 2398
2021
Q3 		$4.09M Sell
238,500
-76,500
-24% -$1.31M ﹤0.01% 2414
2021
Q2 		$5.49M Buy
+315,000
New +$4.32M ﹤0.01% 2302

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments's HOWL Position: Q1 2026 in Review

Fidelity Investments reduced its Werewolf Therapeutics (HOWL) stake by 99% in Q1 2026, selling an estimated $2.46K and leaving 39 shares worth $32. The position accounts for ﹤0.01% of the portfolio, ranked #5323.

Fidelity Investments first reported a position in HOWL in Q2 2021 and has held it in 16 quarters since. The position peaked at $5.49M in Q2 2021. 48 funds tracked by Wall St. Rank hold HOWL as of Q1 2026.

  • Fidelity Investments held 39 shares of Werewolf Therapeutics worth $32 as of Q1 2026.
  • Fidelity Investments sold 3,592 Werewolf Therapeutics shares in Q1 2026, an estimated $2.46K.
  • Werewolf Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #5323 holding.
  • Fidelity Investments first reported a position in Werewolf Therapeutics in Q2 2021 and has held it in 16 quarters since.
  • Fidelity Investments's Werewolf Therapeutics position peaked at $5.49M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.